Processa Pharmaceuticals Inc (PCSA)

Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Income/Loss	29.87%-2.34	-3.33	-3.70	-3.49	-3.95
Nonoperating Income/Loss	-0.93	-	-	-	-
	3.31%-3.27	-3.38	-3.36	-3.44	-3.93
Attributable To Parent	3.31%-3.27	-3.38	-3.36	-3.44	-3.93
Available To Common Stockholders, Basic	3.31%-3.27	-3.38	-3.36	-3.44	-3.93
Basic Average Shares	4.86%2.75	2.62	-	47.53	15.57
Diluted Average Shares	4.86%2.75	2.62	-	47.53	15.57
Basic Earnings Per Share	7.75%-1.19	-1.29	-	-0.07	-0.25
Diluted Earnings Per Share	7.75%-1.19	-1.29	-	-0.07	-0.25